Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1,041 melanoma patients

被引:18
作者
Kibrite, Antoine [1 ]
Milot, Helene [2 ]
Douville, Pierre [3 ]
Gagne, Eric J. [3 ]
Labonte, Sebastien [3 ]
Friede, Juan [4 ]
Morin, Francis [4 ]
Ouellet, Jean-Francois [1 ]
Claveau, Joel [5 ]
机构
[1] CHU Quebec, Dept Surg, Quebec City, PQ G1R 2J6, Canada
[2] Hop Le Royer, Dept Gen Surg, Quebec City, PQ, Canada
[3] CHU Quebec, Dept Med Biol, Quebec City, PQ, Canada
[4] CHU Quebec, Dept Med Imaging, Quebec City, PQ, Canada
[5] CHU Quebec, Dept Dermatol, Quebec City, PQ, Canada
关键词
Melanoma; Sentinel lymph node; Breslow thickness; Mitotic rate; Lymphovascular invasion; Lymphadenectomy; PRIMARY CUTANEOUS MELANOMA; TUMOR MITOTIC RATE; MALIGNANT-MELANOMA; NODAL OBSERVATION; BIOPSY; MULTICENTER; CRITERIA;
D O I
10.1016/j.amjsurg.2015.05.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Sentinel lymph node (SLN) biopsy may identify patients who may need completion lymphadenectomy and adjuvant therapy. METHODS: Univariate and multivariate analysis were conducted for SLN status in a prospective cohort of 1,041 patients. A biopsy was recommended for melanoma greater than or equal to 1 mm thick or greater than or equal to .75 mm with poor prognostic features. RESULTS: For sentinel node status, mitotic rate is very significant in univariate analysis. In multivariate analysis, Breslow, lymphovascular invasion, and primary site were significant. Breslow thickness greater than or equal to 2 mm and SLN with macroscopic burden greater than or equal to 2 mm are the only statistically significant variables predicting the non-SLN status in multivariate analysis. CONCLUSIONS: The data confirm the importance of Breslow, lymphovascular invasion, and body site for SLN status. The cutoff of 2 mm for tumor load in SLN appears to be a simple technique to find the high-risk patients with further lymph node disease. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 22 条
[1]   Sentinel lymph nodes in malignant melanoma - Extended histopathologic evaluation improves diagnostic precision [J].
Abrahamsen, HN ;
Hamilton-Dutoit, SJ ;
Larsen, J ;
Steiniche, T .
CANCER, 2004, 100 (08) :1683-1691
[2]   Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma - An analysis of 3661 patients from a single center [J].
Azzola, MF ;
Shaw, HM ;
Thompson, JF ;
Soong, SJ ;
Scolyer, RA ;
Watson, GF ;
Colman, MH ;
Zhang, YT .
CANCER, 2003, 97 (06) :1488-1498
[3]   Final Version of 2009 AJCC Melanoma Staging and Classification [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Atkins, Michael B. ;
Byrd, David R. ;
Buzaid, Antonio C. ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Ding, Shouluan ;
Eggermont, Alexander M. ;
Flaherty, Keith T. ;
Gimotty, Phyllis A. ;
Kirkwood, John M. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sober, Arthur J. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206
[4]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[5]   The amount of metastatic melanoma in a sentinel lymph node: Does it have prognostic significance? [J].
Carlson, GW ;
Murray, DR ;
Lyles, RH ;
Staley, CA ;
Hestley, A ;
Cohen, C .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (05) :575-581
[6]   Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours [J].
Cochran, AJ ;
Roberts, A ;
Wen, DR ;
Huang, RR ;
Itakura, E ;
Luo, F ;
Binder, SW .
PATHOLOGY, 2004, 36 (05) :478-484
[7]   The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up [J].
Francken, AB ;
Shaw, HM ;
Thompson, JF ;
Soong, SJ ;
Accortt, NA ;
Azzola, MF ;
Scolyer, RA ;
Milton, GW ;
McCarthy, WH ;
Colman, MH ;
McGovern, VJ .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (04) :426-433
[8]  
Houghton A, 1998, ONCOLOGY-NY, V12, P153
[9]  
KRAG DN, 1995, ARCH SURG-CHICAGO, V130, P654
[10]   Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence - A clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy [J].
Li, LXL ;
Scolyer, RA ;
Ka, VSK ;
McKinnon, JG ;
Shaw, HM ;
McCarthy, SW ;
Thompson, JF .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (09) :1197-1202